Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „monotherapy“
Suchtreffer
Begriffe & Kennungen
Calquence · 4.8 · Of the 1 478 patients treated with Calquence monotherapy, the most common (≥ 20%) adverse drug reactions (ADRs
Eintrag öffnenCapecitabine Accord · 4.8 · A meta-analysis of 14 clinical trials with data from over 4700 patients treated with capecitabine monotherapy
Eintrag öffnenCapecitabine Accord · 4.8 · Capecitabine monotherapy Table 5 lists ADRs associated with the use of capecitabine monotherapy based on a poo
Eintrag öffnenCapecitabine Accord · 4.8 · Table 5 Summary of related ADRs reported in patients treated with capecitabine monotherapy Body System Very Co
Eintrag öffnenCapecitabine Teva · 4.8 · A meta-analysis of 14 clinical trials with data from over 4700 patients treated with capecitabine monotherapy
Eintrag öffnenCapecitabine Teva · 4.8 · An analysis of safety data in patients treated with capecitabine monotherapy (colorectal cancer) with baseline
Eintrag öffnenCapecitabine Teva · 4.8 · An analysis of safety data in patients ≥60 years of age treated with capecitabine monotherapy and an analysis
Eintrag öffnenCapecitabine Teva · 4.8 · Capecitabine Monotherapy Table 4 lists ADRs associated with the use of capecitabine monotherapy based on a poo
Eintrag öffnenCapecitabine Teva · 4.8 · Table 4 Summary of related ADRs reported in patients treated with capecitabine monotherapy
Eintrag öffnenCerdelga · 4.8 · In the ELIKIDS paediatric study Cohort 1 (eliglustat monotherapy), the most common adverse reactions were dysp
Eintrag öffnenColumvi · 4.8 · 21 Colitis Colitis (Grade 4) was reported in 1 patient (0.7%) who received Columvi monotherapy, with time to o
Eintrag öffnenColumvi · 4.8 · Adverse reactions occurring in relapsed or refractory DLBCL patients treated with Columvi monotherapy (n=145)
Eintrag öffnenColumvi · 4.8 · Any grade CRS (by ASTCT criteria) occurred in 67.6% of patients who received Columvi monotherapy, with Grade 1
Eintrag öffnenColumvi · 4.8 · Columvi monotherapy The most common adverse reactions (≥ 20%) were cytokine release syndrome, neutropenia, ana
Eintrag öffnenColumvi · 4.8 · Cytokine release syndrome Columvi monotherapy
Eintrag öffnenColumvi · 4.8 · Opportunistic infections CMV events were reported in 6/467 patients (1.3%) who received Columvi monotherapy, w
Eintrag öffnenColumvi · 4.8 · Serious infections Serious infections were reported in 15.9% of patients who received Columvi monotherapy. The
Eintrag öffnenColumvi · 4.8 · The descriptions below reflect information for significant adverse reactions for Columvi monotherapy and/or co
Eintrag öffnenColumvi · 4.8 · Tumour flare Tumour flare was reported in 11.7% of patients who received Columvi monotherapy, including Grade
Eintrag öffnenColumvi · 4.8 · Tumour lysis syndrome TLS was reported in 2 patients (1.4%) who received Columvi monotherapy and was Grade 3 i
Eintrag öffnen